Scientific committee

The genetic evaluation tools of Patia arise from the detailed analysis of the results of the biggest scientific studies and meta-analysis of the human genome that have been carried out in relation to type 2 diabetes.

  • The DIAGRAM Consortium
  • The T2D-GENES Consortium
  • The SIGMA initiative of the Carlos Slim Foundation, the Broad Institute, associated with the MIT and Harvard University.

In this process, Patia, in collaboration with the scientists and doctors of the SIGMA project, selected the genetic variants associated with the type 2 diabetes and gestational diabetes that Diabetes Predict and Diabetes Pregest analyse.

Scientific Committee that endorses the Diabetes Prevent programme

In addition to the scientists and doctors who participate in the SIGMA project, Patia also consults with a group of renowned doctors and scientists with long professional careers in the fight against diabetes.

Dr. Jaakko Tuomilehto
Dr. Jaakko TuomilehtoCreator of the Findrisk test Emeritus Professor of Public Health, University of Helsinki, Finland
Dr. Jaime Berumen
Dr. Jaime BerumenProfessor Head of the Genomic Medicine Unit General Hospital of Mexico – Faculty of Medicine at UNAM.
Dr. Michel Marre
Dr. Michel MarreDirector of the Diabetes Department of Hospitalier Bichat-Claude Bernard in Paris, France and professor at the University of Paris, France
Dr. Rafael Gabriel
Dr. Rafael GabrielHead of Research Methodology Unit Universidad Autónoma de Madrid (Spain)